eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
a sign at a planned parenthood clinic is pictured in oklahoma city, in 2015.
.
. "the importance of our new method is that it allows for precise and automated measurement of the disease," bentley added in the study published in the journal radiology.
. the hearings in the european parliament with the participation of the founder of facebook , mark zuckerberg, will pass in the closed mode.
.